JEMAPETE CHRISTOPHER J purchased 14.3% of their position (500K shares) of GENE BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $92.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/18/2021ACC: 0001493152-21-006314
10% Owner
Since Feb 2021
+500K
Net shares
Net buyer
$92.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
500K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+300K
Price / share
$0.04
Trade value
$11.97K
% of position
8.6%
3/16/2021
3.50M→3.80M
Common Stock
Direct
Shares
+200K
Price / share
$0.40
Trade value
$80.40K
% of position
5.3%
3/17/2021
3.80M→4M
Total
Net shares
+500K
Net value
$92.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2021 | P · Purchase | +300K | $0.04 | $11.97K | 8.6% | 3.50M | 3.80M |
| Common Stock Direct | 3/17/2021 | P · Purchase | +200K | $0.40 | $80.40K | 5.3% | 3.80M | 4M |
| Total | +500K | $92.37K | ||||||
Derivative Transactions0
No derivative transactions reported